Dermapharm Holding SE (ETR:DMP)

Market Cap	1.80B
Revenue (ttm)	1.20B
Net Income (ttm)	103.57M
Shares Out	53.84M
EPS (ttm)	1.92
PE Ratio	17.42
Forward PE	14.00
Dividend	0.90 (2.71%)
Ex-Dividend Date	Jun 27, 2025

Volume	12,903
Average Volume	13,730
Open	33.25
Previous Close	33.20
Day's Range	33.15 - 33.70
52-Week Range	30.15 - 42.50
Beta	1.28
RSI	38.43
Earnings Date	Aug 26, 2025

About Aerovate Therapeutics

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as product...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 3,610
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: DMP

Financial Performance

In 2024, Dermapharm Holding SE's revenue was 1.20 billion, an increase of 3.89% compared to the previous year's 1.15 billion. Earnings were 113.79 million, an increase of 82.44%.